首页|隔离液注射在预防甲状腺结节射频消融术并发症中的应用

隔离液注射在预防甲状腺结节射频消融术并发症中的应用

扫码查看
目的 探讨隔离液注射在预防甲状腺结节射频消融术(RFA)并发症的临床效果.方法 回顾性研究2022年9月—2024年3月接受超声引导下射频消融治疗的甲状腺结节患者78例(男17例,女61例),平均年龄(37.8±1.63)岁,其中结节性甲状腺肿51例,甲状腺微小乳头状癌27例.在术中操作期间,所有患者均在结节邻近区域的甲状腺被膜与喉返神经、颈动脉或气管、食管、甲状旁腺间隙注射隔离液,术后观察有无声音嘶哑、低钙血症发生,记录甲状旁腺素和血钙变化情况.结果 78例患者均顺利完成超声引导下甲状腺结节射频消融治疗,手术操作总时间为(29.3±6.7)min,术后无一例患者出现术区血肿、低钙血症、声音嘶哑等并发症,甲状旁腺素和血钙较术前变化差异无统计学意义(P>0.05).结论 隔离液注射可有效预防甲状腺结节射频消融术喉返神经和气管、食管灼伤等并发症的发生.
Application of isolation fluid injection in preventing complications of radio frequency ablation for thyroid nodules
Objective To investigate the clinical effect of isolation fluid injection in preventing the complications of radio frequency ablation (RFA) of thyroid nodules.Methods A retrospective study was conducted on 78 patients with thyroid nodules ( 17 males and 61 females) who received ultrasound-guided RFA from September 2022 to March 2024,with an aver-age age of (37.8±1.63) years,including 51 cases of nodular goiter and 27 cases of thyroid micropapillary carcinoma.Dur-ing operation,all patients were injected into thyroid capsule and recurrent laryngeal nerve,carotid artery or trachea,esophagus and parathyroid space near nodal areas.Postoperative observation was made for hoarseness and hypocalcemia,and the changes of parathyroid hormone and blood calcium were recorded.Results All the 78 patients successfully completed the ultrasound-guided RFA of thyroid nodules,and total operation time was (29.3±6.7) min.Postoperative complications such as intraoperative hematoma,hypocalcemia,hoarseness and other complications occurred in none of the patients,and the changes of parathyroid hormone and blood calcium were not significantly different compared with those before surgery ( P>0.05).Conclusion Isolation fluid injection can effectively prevent recurrent laryngeal nerve and tracheal and esophageal burns during the RFA of thyroid nodules.

radio frequency ablation (RFA)thyroid nodulecomplicationsurgical safety

黄仁相、杨钦云、洪运虎、王桂林

展开 >

桂林医学院第二附属医院乳腺甲状腺外科,广西桂林541199

射频消融 甲状腺结节 并发症 手术安全性

2024

右江医学
右江民族医学院附属医院

右江医学

影响因子:0.779
ISSN:1003-1383
年,卷(期):2024.52(10)